SMTL ID : 7wf3.1

Composite map of human Kv1.3 channel in apo state with beta subunits

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-4-4-4-mer

Ligands

4 x K: POTASSIUM ION(Non-functional Binders)(Non-covalent)

K.1: 0 residues within 4Å: (No contacts) No protein-ligand interaction detected (PLIP) K.2: 8 residues within 4Å: Chain A: T.237, V.238 Chain C: T.237, V.238 Chain D: T.237, V.238 Chain F: T.237, V.238 4 PLIP interactions: 1 interactions with chain A, 1 interactions with chain F, 1 interactions with chain C, 1 interactions with chain D Metal complexes: A:V.238, F:V.238, C:V.238, D:V.238 K.3: 5 residues within 4Å: Chain A: T.237 Chain C: T.237 Chain D: T.237 Chain F: T.237 Ligands: K.4 No protein-ligand interaction detected (PLIP) K.4: 1 residues within 4Å: Ligands: K.3 No protein-ligand interaction detected (PLIP)

4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.5: 30 residues within 4Å: Chain B: G.22, T.23, W.24, Q.30, D.52, Y.57, K.85, N.125, S.155, R.156, Q.181, W.210, S.211, P.212, L.213, A.214, C.215, G.216, S.219, K.221, S.230, R.231, P.271, L.288, L.289, G.290, S.292, Q.296, E.299, N.300 26 PLIP interactions: 26 interactions with chain B Hydrogen bonds: B:W.24, B:Q.30, B:D.52, B:D.52, B:K.85, B:S.155, B:S.155, B:R.156, B:L.213, B:C.215, B:S.219, B:K.221, B:R.231, B:R.231, B:L.289, B:G.290, B:S.292, B:Q.296, B:N.300, B:N.300 Water bridges: B:N.125 Salt bridges: B:K.221, B:R.231 pi-Stacking: B:W.24, B:W.210, B:W.210 NAP.6: 30 residues within 4Å: Chain E: G.22, T.23, W.24, Q.30, D.52, Y.57, K.85, N.125, S.155, R.156, Q.181, W.210, S.211, P.212, L.213, A.214, C.215, G.216, S.219, K.221, S.230, R.231, P.271, L.288, L.289, G.290, S.292, Q.296, E.299, N.300 28 PLIP interactions: 28 interactions with chain E Hydrogen bonds: E:T.23, E:W.24, E:Q.30, E:D.52, E:D.52, E:K.85, E:S.155, E:S.155, E:R.156, E:L.213, E:C.215, E:S.219, E:K.221, E:R.231, E:R.231, E:R.231, E:L.289, E:G.290, E:S.292, E:Q.296, E:N.300, E:N.300 Water bridges: E:N.125 Salt bridges: E:K.221, E:R.231 pi-Stacking: E:W.24, E:W.210, E:W.210 NAP.7: 30 residues within 4Å: Chain G: G.22, T.23, W.24, Q.30, D.52, Y.57, K.85, N.125, S.155, R.156, Q.181, W.210, S.211, P.212, L.213, A.214, C.215, G.216, S.219, K.221, S.230, R.231, P.271, L.288, L.289, G.290, S.292, Q.296, E.299, N.300 26 PLIP interactions: 26 interactions with chain G Hydrogen bonds: G:W.24, G:Q.30, G:D.52, G:D.52, G:K.85, G:S.155, G:S.155, G:R.156, G:L.213, G:C.215, G:S.219, G:K.221, G:R.231, G:R.231, G:L.289, G:G.290, G:S.292, G:Q.296, G:N.300, G:N.300 Water bridges: G:N.125 Salt bridges: G:K.221, G:R.231 pi-Stacking: G:W.24, G:W.210, G:W.210 NAP.8: 30 residues within 4Å: Chain I: G.22, T.23, W.24, Q.30, D.52, Y.57, K.85, N.125, S.155, R.156, Q.181, W.210, S.211, P.212, L.213, A.214, C.215, G.216, S.219, K.221, S.230, R.231, P.271, L.288, L.289, G.290, S.292, Q.296, E.299, N.300 27 PLIP interactions: 27 interactions with chain I Hydrogen bonds: I:T.23, I:W.24, I:Q.30, I:D.52, I:D.52, I:K.85, I:S.155, I:S.155, I:R.156, I:L.213, I:C.215, I:S.219, I:K.221, I:R.231, I:R.231, I:L.289, I:G.290, I:S.292, I:Q.296, I:N.300, I:N.300 Water bridges: I:N.125 Salt bridges: I:K.221, I:R.231 pi-Stacking: I:W.24, I:W.210, I:W.210

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tyagi, A. et al., Rearrangement of a unique Kv1.3 selectivity filter conformation upon binding of a drug. Proc.Natl.Acad.Sci.USA (2022)

Release Date

2022-02-09

Peptides

Potassium voltage-gated channel subfamily A member 3: ACDF
Voltage-gated potassium channel subunit beta-2: BEGI
Potassium voltage-gated channel subfamily A member 3: HJKL

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

C
D

D
F

F
H

B
C

E
G

G
I

I
M

H
J

J
N

K
O

L
P

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Potassium voltage-gated channel subfamily A member 3

Voltage-gated potassium channel subunit beta-2

Potassium voltage-gated channel subfamily A member 3

Related Entries With Identical Sequence